RxDoctor Payments Data

Brielle Brown

Nurse Practitioner · Lake City, FLNPI 1760817175

Payments from drug & device makers

$8,342in general payments, 2019–2025

Across 408 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$660
  • AstraZeneca$617
  • Seagen Inc.$574
  • Amgen$527
  • Johnson & Johnson$487
  • Lilly USA, LLC$357
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$7,77193%
  • Education$5717%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis42$660
AstraZeneca(2 entities)31$617
Seagen Inc.22$574
Amgen23$527
Johnson & Johnson26$487
Lilly USA, LLC17$357
Takeda Pharmaceuticals U.S.A., Inc.13$299
Daiichi Sankyo Inc.14$286
Jazz Pharmaceuticals Inc.10$274
Merck13$257
Pfizer14$250
E.r. Squibb & Sons, L.L.C.12$244
Bristol Myers Squibb10$195
Ipsen Biopharmaceuticals, Inc8$178
Eisai Inc.9$175
Sanofi7$154
G1 Therapeutics, Inc.4$146
Incyte Corporation9$144
Myriad Genetic Laboratories, Inc.2$142
EMD Serono, Inc.6$133
Sobi, Inc5$131
GSK6$116
Regeneron Healthcare Solutions, Inc.6$107
Taiho Oncology, Inc.5$105
Karyopharm Therapeutics Inc.5$95
Agios Pharmaceuticals, Inc.5$93
Pharmaessentia USA Corporation4$92
Gilead4$91
AbbVie4$84
Genmab U.S., Inc.3$83
Astellas Pharma US Inc5$81
Pharmacosmos Therapeutics Inc.3$80
Array Biopharma Inc5$78
Bayer3$75
Blueprint Medicines Corporation3$68
Boehringer Ingelheim3$58
Kyowa Kirin, Inc.3$56
Mirati Therapeutics, Inc.3$51
Stemline Therapeutics Inc.2$50
CSL Behring3$43
Octapharma USA, Inc.2$42
Rigel Pharmaceuticals, Inc.2$37
Genentech USA, Inc.2$37
Servier Pharmaceuticals LLC2$37
Adaptive Biotechnologies Corporation2$36
Exelixis Inc.2$35
Morphosys, US Inc.2$34
Legend Biotech USA Inc.2$29
Puma Biotechnology, Inc.2$28
Pharmacyclics LLC, An Abbvie Company2$27
Deciphera Pharmaceuticals Inc.2$26
Azurity Pharmaceuticals, Inc.1$25
Springworks Therapeutics, Inc.1$25
Dova Pharmaceuticals1$23
AMAG Pharmaceuticals, Inc.1$21
Heron Therapeutics, Inc.1$20
ADC Therapeutics America, Inc.1$18
EUSA Pharma (US) LLC1$17
AVEO Pharmaceuticals, Inc.1$16
Novocure Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,342 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$48,205
Ondansetron OdtOndansetron41$763
Prochlorperazine Maleate25$576
Dexamethasone16$479
Anastrozole38$478
Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12)25$441
Potassium Chloride42$324
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine15$314
Hydroxyurea20$301
Prednisone36$204
Pregabalin16$197
Mirtazapine21$167
Pantoprazole Sodium43$165
Zolpidem Tartrate16$161
Methocarbamol11$147

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$250$48,20560 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Lake City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →